Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 19 studies | 26% ± 13% | |
pericyte | 8 studies | 29% ± 15% | |
fibroblast | 8 studies | 24% ± 7% | |
GABAergic neuron | 7 studies | 33% ± 17% | |
interneuron | 6 studies | 35% ± 21% | |
smooth muscle cell | 6 studies | 26% ± 7% | |
adipocyte | 6 studies | 23% ± 6% | |
astrocyte | 6 studies | 31% ± 12% | |
endothelial cell of lymphatic vessel | 5 studies | 21% ± 4% | |
type I pneumocyte | 5 studies | 24% ± 6% | |
basal cell | 4 studies | 31% ± 24% | |
glutamatergic neuron | 4 studies | 26% ± 6% | |
type II pneumocyte | 4 studies | 20% ± 5% | |
GABAergic interneuron | 3 studies | 24% ± 10% | |
neuron | 3 studies | 17% ± 1% | |
myofibroblast cell | 3 studies | 29% ± 5% | |
epithelial cell | 3 studies | 36% ± 12% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 7% | |
capillary endothelial cell | 3 studies | 19% ± 5% | |
chondrocyte | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 6908.83 | 245 / 245 | 99% | 46.16 | 499 / 502 |
thymus | 100% | 4314.85 | 650 / 653 | 97% | 25.57 | 584 / 605 |
esophagus | 100% | 12572.08 | 1445 / 1445 | 96% | 32.72 | 175 / 183 |
skin | 100% | 6075.32 | 1808 / 1809 | 95% | 38.07 | 450 / 472 |
uterus | 100% | 5317.06 | 170 / 170 | 92% | 24.47 | 421 / 459 |
lung | 100% | 6086.82 | 576 / 578 | 89% | 19.46 | 1031 / 1155 |
pancreas | 94% | 2360.60 | 309 / 328 | 94% | 16.92 | 167 / 178 |
breast | 100% | 5112.15 | 459 / 459 | 85% | 15.99 | 945 / 1118 |
kidney | 81% | 1893.10 | 72 / 89 | 92% | 20.61 | 826 / 901 |
bladder | 100% | 11081.90 | 21 / 21 | 70% | 13.74 | 351 / 504 |
brain | 63% | 1247.49 | 1661 / 2642 | 99% | 24.66 | 700 / 705 |
adrenal gland | 71% | 1533.78 | 183 / 258 | 75% | 42.54 | 173 / 230 |
stomach | 76% | 4183.14 | 274 / 359 | 60% | 11.75 | 171 / 286 |
ovary | 67% | 1613.14 | 121 / 180 | 69% | 10.32 | 295 / 430 |
intestine | 85% | 8895.95 | 825 / 966 | 41% | 6.09 | 216 / 527 |
liver | 66% | 1346.88 | 149 / 226 | 53% | 8.12 | 215 / 406 |
adipose | 100% | 5069.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 24828.34 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.60 | 1 / 1 |
blood vessel | 100% | 6775.56 | 1334 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 30.01 | 44 / 45 |
spleen | 95% | 2400.75 | 228 / 241 | 0% | 0 | 0 / 0 |
heart | 94% | 3836.58 | 810 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 11.99 | 71 / 80 |
lymph node | 0% | 0 | 0 / 0 | 48% | 3.58 | 14 / 29 |
peripheral blood | 2% | 35.51 | 16 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0030334 | Biological process | regulation of cell migration |
GO_0035329 | Biological process | hippo signaling |
GO_0003365 | Biological process | establishment of cell polarity involved in ameboidal cell migration |
GO_0008180 | Cellular component | COP9 signalosome |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | AMOTL1 |
Protein name | Angiomotin like 1 Angiomotin-like protein 1 |
Synonyms | |
Description | FUNCTION: Inhibits the Wnt/beta-catenin signaling pathway, probably by recruiting CTNNB1 to recycling endosomes and hence preventing its translocation to the nucleus. . |
Accessions | ENST00000317829.12 [Q8IY63-2] F8WDH4 ENST00000299004.13 Q8IY63 ENST00000433060.3 [Q8IY63-1] |